{"id":3548,"date":"2023-07-25T07:40:57","date_gmt":"2023-07-25T13:40:57","guid":{"rendered":"https:\/\/udibi6748.live-website.com\/?page_id=3548"},"modified":"2023-07-25T07:42:36","modified_gmt":"2023-07-25T13:42:36","slug":"what-is-transferon-oral","status":"publish","type":"page","link":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/","title":{"rendered":"Transferon Oral\u00ae"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<strong>What is Transferon Oral\u00ae?<\/strong><\/p>\n<p>Transferon Oral\u00ae is a dialyzable extract of leukocytes, composed of a mixture of 60 low-molecular weight peptides, which appear consistently and reproducibly in each batch.<\/p>\n<p>The sequence and composition of all the peptides of Transferon Oral\u00ae have been determined, published, and protected by the IPN.<\/p>\n<p>Transferon Oral\u00ae is indicated for the treatment of conditions with a significant inflammatory component, in which it has been shown that it can favor the course of recovery.<\/p>\n<p>Its mechanism of action can be explained through the binding of its peptide components to its receptors, particularly monomeric ubiquitin.<\/p>\n<p>Among the most important immunological changes induced by Transferon Oral\u00ae is the down-modulation of some proinflammatory cytokines and the up-modulation of gamma interferon.<\/p>\n<p>It is a useful immunomodulator in:<\/p>\n<ul>\n<li>Allergic diseases.<\/li>\n<li>Repeat infections.<\/li>\n<li>Autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus).<\/li>\n<li>Immunosuppressions due to the application of cytotoxic oncological treatments (breast, cervical-uterine, prostate, colon cancer).<\/li>\n<\/ul>\n<p>Vallejo-Castillo L, et al. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract \u00abTransferon Oral\u00bb: The Starting Point to Understand Its Mechanism of Action. Front Pharmacol. 2020 Oct 7;11:569039. doi: 10.3389\/fphar.2020.569039.<\/p>\n<p><strong>Reference<\/strong><\/p>\n<p>Vallejo-Castillo L, et al. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract \u00abTransferon Oral\u00bb: The Starting Point to Understand Its Mechanism of Action. Front Pharmacol. 2020 Oct 7;11:569039. doi: 10.3389\/fphar.2020.569039.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]What is Transferon Oral\u00ae? Transferon Oral\u00ae is a dialyzable extract of leukocytes, composed of a mixture of 60 low-molecular weight peptides, which appear consistently and reproducibly in each batch. The sequence and composition of all the peptides of Transferon Oral\u00ae have been determined, published, and protected by the IPN. Transferon Oral\u00ae is indicated for the treatment of conditions with a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"pmpro_default_level":"","footnotes":""},"class_list":["post-3548","page","type-page","status-publish","hentry","pmpro-has-access"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Transferon Oral\u00ae - UDIBI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transferon Oral\u00ae - UDIBI\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text]What is Transferon Oral\u00ae? Transferon Oral\u00ae is a dialyzable extract of leukocytes, composed of a mixture of 60 low-molecular weight peptides, which appear consistently and reproducibly in each batch. The sequence and composition of all the peptides of Transferon Oral\u00ae have been determined, published, and protected by the IPN. Transferon Oral\u00ae is indicated for the treatment of conditions with a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIBI\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-25T13:42:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/\",\"url\":\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/\",\"name\":\"Transferon Oral\u00ae - UDIBI\",\"isPartOf\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\"},\"datePublished\":\"2023-07-25T13:40:57+00:00\",\"dateModified\":\"2023-07-25T13:42:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/udibi.com.mx\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transferon Oral\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\",\"url\":\"https:\/\/udibi.com.mx\/en\/\",\"name\":\"UDIBI\",\"description\":\"IPN\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udibi.com.mx\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transferon Oral\u00ae - UDIBI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/","og_locale":"en_US","og_type":"article","og_title":"Transferon Oral\u00ae - UDIBI","og_description":"[vc_row][vc_column][vc_column_text]What is Transferon Oral\u00ae? Transferon Oral\u00ae is a dialyzable extract of leukocytes, composed of a mixture of 60 low-molecular weight peptides, which appear consistently and reproducibly in each batch. The sequence and composition of all the peptides of Transferon Oral\u00ae have been determined, published, and protected by the IPN. Transferon Oral\u00ae is indicated for the treatment of conditions with a [&hellip;]","og_url":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/","og_site_name":"UDIBI","article_modified_time":"2023-07-25T13:42:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/","url":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/","name":"Transferon Oral\u00ae - UDIBI","isPartOf":{"@id":"https:\/\/udibi.com.mx\/en\/#website"},"datePublished":"2023-07-25T13:40:57+00:00","dateModified":"2023-07-25T13:42:36+00:00","breadcrumb":{"@id":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/udibi.com.mx\/en\/what-is-transferon-oral\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/udibi.com.mx\/en\/"},{"@type":"ListItem","position":2,"name":"Transferon Oral\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/udibi.com.mx\/en\/#website","url":"https:\/\/udibi.com.mx\/en\/","name":"UDIBI","description":"IPN","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udibi.com.mx\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/3548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/comments?post=3548"}],"version-history":[{"count":3,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/3548\/revisions"}],"predecessor-version":[{"id":3551,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/3548\/revisions\/3551"}],"wp:attachment":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/media?parent=3548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}